Back
Fulcrum Therapeutics, Inc. Stock Price Chart
Bitcoin was First. NatGold is the Masterpiece.
Reserve Your Tokens Now
Buy
67
FULC
Fulcrum Therapeutics, Inc.
Last Price:
$10.49
Seasonality Move:
-23.08%
7 Day Trial
ALL ACCESS PASS
$
7
Before There's a Price, There's a Position: NatGold Pre-Market
Secure your position now-before access is controlled by price.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FULC is experiencing slight selling pressure.
Fulcrum Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.82 | Sell |
| 20-day SMA: | 10.45 | Buy |
| 50-day SMA: | 11.11 | Sell |
| 200-day SMA: | 8.14 | Buy |
| 8-day EMA: | 5.71 | Buy |
| 20-day EMA: | 2.8 | Buy |
| 50-day EMA: | 1.22 | Buy |
| 200-day EMA: | 0.32 | Buy |
Fulcrum Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.03 | Buy |
| Relative Strength Index (14 RSI): | 49.58 | Sell |
| Chaikin Money Flow: | -113459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.07 - 11.31) | Buy |
| Bollinger Bands (100): | (8.15 - 11.51) | Buy |
Fulcrum Therapeutics, Inc. Technical Analysis
| Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics, Inc. Stock
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 10.72 while FULC 8-day simple moving average is 10.82, which is a Sell signal.
-
The stock price of FULC is 10.72 while Fulcrum Therapeutics, Inc. 20-day SMA is 10.45, which makes it a Buy.
-
Fulcrum Therapeutics, Inc. 50-day simple moving average is 11.11 while FULC share price is 10.72, making it a Sell technically.
-
FULC stock price is 10.72 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 8.14, creating a Buy signal.
FULC Technical Analysis vs Fundamental Analysis
Buy
67
Fulcrum Therapeutics, Inc. (FULC)
is a Buy
Is Fulcrum Therapeutics, Inc. a Buy or a Sell?
-
Fulcrum Therapeutics, Inc. stock is rated a BuyThe current Fulcrum Therapeutics, Inc. [FULC] share price is $10.72. The Score for FULC is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Fulcrum Therapeutics, Inc. Stock Info
Market Cap:
580.1M
Price in USD:
10.72
Share Volume:
496.9K
Fulcrum Therapeutics, Inc. 52-Week Range
52-Week High:
15.74
52-Week Low:
2.32
Buy
67
Fulcrum Therapeutics, Inc. (FULC)
is a Buy
Fulcrum Therapeutics, Inc. Share Price Forecast
-
What is the Fulcrum Therapeutics, Inc. stock price today?The Fulcrum Therapeutics, Inc. stock price is 10.72 USD today.
-
Will FULC stock go up or go down?Fulcrum Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Fulcrum Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics, Inc. is not overvalued.
Is Fulcrum Therapeutics, Inc. Stock a Buy?
-
Fulcrum Therapeutics, Inc. share price is 10.72 while FULC 8-day exponential moving average is 5.71, which is a Buy signal.
-
The stock price of FULC is 10.72 while Fulcrum Therapeutics, Inc. 20-day EMA is 2.80, which makes it a Buy.
-
Fulcrum Therapeutics, Inc. 50-day exponential moving average is 1.22 while FULC share price is 10.72, making it a Buy technically.
-
FULC stock price is 10.72 and Fulcrum Therapeutics, Inc. 200-day simple moving average is 0.32, creating a Buy signal.
Fundamental Analysis of Fulcrum Therapeutics, Inc.
Is Fulcrum Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Fulcrum Therapeutics, Inc.
Should I short Fulcrum Therapeutics, Inc. stock?
-
FULC Moving Average Covergence Divergence (MACD) indicator is 2.03, suggesting Fulcrum Therapeutics, Inc. is a Buy
-
Fulcrum Therapeutics, Inc. Relative Strength Index (RSI) is 49.58, which suggest Fulcrum Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Fulcrum Therapeutics, Inc. is (10.07 - 11.31), which suggest Fulcrum Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Fulcrum Therapeutics, Inc. is (8.15 - 11.51), which suggest Fulcrum Therapeutics, Inc. is a Buy
* Fulcrum Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.